Because HMGB1 is involved in both cholesterol metabolism[31] and the inflammatory response[41], we hypothesized that rosuvastatin could serve as an anti-inflammatory agent by regulating HMGB1 in IDD. Here, HMGB1 is linked to intervertebral disk degenerative disorder.